Hospital Clínic Barcelona and the FERO Foundation have signed an agreement whereby the foundation joins the Clínic Barcelona Comprehensive Cancer Cen1
The international DESTINY-Breast05 trial, published in The New England Journal of Medicine, demonstrates that the antibody-drug conjugate trastu1
Hospital Clínic Barcelona and IDIBAPS, through the Clínic Barcelona Comprehensive Cancer Centre (4CB), had a prominent presence at the ASH 2025 Annua1
Hospitals that are part of the C17 alliance have launched the C17 Integrated Cancer Network (XIC-C17), an initiative aimed at strengthening coordinat1
Today, 17 November, we mark World Lung Cancer Day — an occasion to raise awareness of this disease, acknowledge the efforts of patients and families,1
The Barcelona Clínic Liver Cancer (BCLC) group, within the framework of the Clínic Barcelona Comprehensive Cancer Center —a center promoted by Clínic1
An international controlled clinical study published in The New England Journal of Medicine demonstrates that liquid biopsy can help identify which p1
The Clínic Barcelona Comprehensive Cancer Center (4CB), a center promoted by Clínic, IDIBAPS and the University of Barcelona, has presented a total o1
"La Caixa" Foundation will allocate €150,000 to the project led by Alba Rodríguez, from the IDIBAPS Cellular Immunotherapies for Cancer research grou1
A study led by the Clínic Barcelona Comprehensive Cancer Center —a center driven by Clínic-IDIBAPS and the University of Barcelona (UB)— demonstrates1
